Budapest, Hungary

Marta Kruppa

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Kruppa: Innovator in Pharmaceutical Chemistry

Introduction

Marta Kruppa is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative processes in compound preparation. Her work has led to the development of valuable chemical compounds that have potential applications in various industries.

Latest Patents

Marta holds a patent for a process titled "Process for preparing alpha-amino-phenylacetic acid-trifluoromethane." This patent outlines a method for synthesizing a compound of the Formula (VI), where X can be a hydrogen atom or OH. This innovative process showcases her expertise in chemical synthesis and her commitment to advancing pharmaceutical research.

Career Highlights

Marta is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company in Hungary. Her role at the company has allowed her to apply her knowledge and skills in a practical setting, contributing to the development of new pharmaceutical products. With 1 patent to her name, she has established herself as a key player in her field.

Collaborations

Throughout her career, Marta has collaborated with esteemed colleagues such as Karoly Ban and Lajosne Pali. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of her work.

Conclusion

Marta Kruppa's contributions to pharmaceutical chemistry through her innovative processes and collaborations highlight her importance in the field. Her dedication to research and development continues to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…